Profiel
Mr. Max H.
Mitteregger is a Founder & Owner at Max Mitteregger Kapitalförvaltning AB. He is on the Board of Directors at Max Mitteregger Kapitalförvaltning AB.
He has about 25 years of experience working in the financial sector, including as a partner, one of the founders and Head of Equity Sales at ABG Sundal Collier and Head of Sales at Carnegie.
Actieve functies van Max Mitteregger
| Bedrijven | Functie | Begin |
|---|---|---|
Max Mitteregger Kapitalförvaltning AB
Max Mitteregger Kapitalförvaltning AB Investment ManagersFinance MMK aims to over time and with a balanced risk-taking give the shareholders an absolute return on invested capital, regardless of the general market. The firm invests the Fund in long positions that are expected to increase in value and short positions that are expected to decrease in value. The fund’s assets are invested in transferable securities, money market instruments, derivatives (including OTC derivatives), exchange traded funds (known as ETFs) and on account with credit institutes. | Oprichter | 24-11-2004 |
Galba Holding AB | Algemeen Directeur | - |
Eerdere bekende functies van Max Mitteregger
| Bedrijven | Functie | Einde |
|---|---|---|
| LIDDS AB | Directeur/Bestuurslid | 02-07-2023 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Max Mitteregger Kapitalförvaltning AB
Max Mitteregger Kapitalförvaltning AB Investment ManagersFinance MMK aims to over time and with a balanced risk-taking give the shareholders an absolute return on invested capital, regardless of the general market. The firm invests the Fund in long positions that are expected to increase in value and short positions that are expected to decrease in value. The fund’s assets are invested in transferable securities, money market instruments, derivatives (including OTC derivatives), exchange traded funds (known as ETFs) and on account with credit institutes. | Finance |
LIDDS AB
LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Galba Holding AB |
















